Research: Probiotic improves symptomatic and viral clearance in Covid19 outpatients
Primary outcome of complete remission on day 30 was achieved by 78 (53.1%) in the probiotic group compared to 41 (28.1%) in placebo.
Patients in probiotic group reported significantly less days of fever, cough, headache, body aches (myalgia), shortness of breath (dyspnea), nausea, diarrhea and abdominal pain.
Research paper: Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial
Image by RENE RAUSCHENBERGER from Pixabay
** This post was originally published on January 18, 2022 **